Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:37 PM
Ignite Modification Date:
2025-12-24 @ 4:37 PM
NCT ID:
NCT07122466
Eligibility Criteria:
Inclusion Criteria:
Prior/Concurrent Therapy Criteria
1. Patients must be initiating a new treatment regimen for pancreatic cancer at the time of their initiation in the study
2. Patients must have cytologic or histologic confirmation of pancreatic cancer
3. Patients must have measurable radiographic evidence of metastatic disease
4. Patients must be ≥18 years of age
5. Patients must have an ECOG Performance Status 0-2.
6. Patients must have adequate organ function for delivery of chemotherapy as evidenced by the following: Hgb ≥8 g/dL, platelets ≥ 75
7. Patients must not have renal dysfunction that would prevent administration of IV contrast for radiographic assessment.
Regulatory Criteria
8. Patients must be informed of the investigational nature of this study and must sign and give written informed consent for this protocol in accordance with institutional and federal guidelines.
9. Patients of all races, genders, \& ethnicities are eligible.
Exclusion Criteria:
No exclusion criteria.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT07122466
Study Brief:
Protocol Section:
NCT07122466